The PMP team 2019 included Frederik, Anne, Brian, Joakim and Lærke.
Frederik graduated from Medical School at the University of
Copenhagen in 2016 and obtained his PhD in spinal surgery in 2018,
before joining Novo Nordisk and the PMP in 2019. During his rotations,
Frederik worked with obesity in Global Medical Affairs, diabetes in
Medical & Science and insulins in Global Safety. After completing
the PMP program, Frederik took up a position as Medical Manager in the
Danish Novo Nordisk Affiliate (Novo Nordisk Denmark), with
responsibility for ‘New Therapy Areas’ (NASH, CVD & Alzheimer’s disease).
Anne graduated from University of Copenhagen in 2008 and obtained
her PhD degree from Centre for Pregnancy and Heart Disease,
Rigshospitalet and University of Copenhagen in 2018. During her PMP
rotations, Anne worked with diabetes, obesity, Alzheimer’s disease and
cardiovascular diseases. After completing the PMP programme, she
joined the Cardiovascular Diseases team in Global Medical Affairs.
Brian graduated from the University of Southern Denmark in 2014 and
obtained his PhD in medical and molecular imaging from the University
of Copenhagen at the Department of Radiology at Rigshospitalet. His
PMP programme started in Global Medical Affairs working with
non-alcoholic steatohepatitis before moving to Safety Surveillance
Biopharm, GLP-1 Diabetes and Devices. In his final position in Medical
& Science, Brian worked with lipid-lowering drug development
before growing his roots in the GLP-1 Diabetes team where he got his
permanent position as Senior International Medical Manager.
Joakim graduated from Lund University in Lund, Sweden in 2015 and
did his post-graduate clinical rotations at Skåne University Hospital
in Malmö, Sweden. In 2018, he defended his PhD thesis at Karolinska
institutet, Stockholm, Sweden, on the epidemiology of antibiotic
resistant gut bacteria in Guinea-Bissau and Sweden. During the PMP
program, Joakim worked with various diseases and products in the Novo
Nordisk portfolio before landing a final position in Global Safety.
Joakim is also manager for the current PMP team.
Lærke graduated as a medical doctor from the University of
Copenhagen in 2012 and went on to practise medicine. In 2019, she
defended her PhD thesis in the field of cardiovascular epidemiology
before joining Novo Nordisk. After working mainly with growth hormones
and sickle cell disease in Safety Surveillance, Lærke supported
post-marketing activities for a once-daily basal insulin in Global
Medical Affairs. After working on an early-phase project and
developing potential future clinical studies on a treatment for NASH
in Medical & Science, Lærke took up a final position within
Medical & Science Obesity.